659 related articles for article (PubMed ID: 26414932)
1. Human Induced Pluripotent Stem Cell NEUROG2 Dual Knockin Reporter Lines Generated by the CRISPR/Cas9 System.
Li S; Xue H; Wu J; Rao MS; Kim DH; Deng W; Liu Y
Stem Cells Dev; 2015 Dec; 24(24):2925-42. PubMed ID: 26414932
[TBL] [Abstract][Full Text] [Related]
2. Efficient generation of hiPSC neural lineage specific knockin reporters using the CRISPR/Cas9 and Cas9 double nickase system.
Li S; Xue H; Long B; Sun L; Truong T; Liu Y
J Vis Exp; 2015 May; (99):e52539. PubMed ID: 26065872
[TBL] [Abstract][Full Text] [Related]
3. Homology arms of targeting vectors for gene insertions and CRISPR/Cas9 technology: size does not matter; quality control of targeted clones does.
Petrezselyova S; Kinsky S; Truban D; Sedlacek R; Burtscher I; Lickert H
Cell Mol Biol Lett; 2015 Dec; 20(5):773-87. PubMed ID: 26540224
[TBL] [Abstract][Full Text] [Related]
4. Generation and validation of PAX7 reporter lines from human iPS cells using CRISPR/Cas9 technology.
Wu J; Hunt SD; Xue H; Liu Y; Darabi R
Stem Cell Res; 2016 Mar; 16(2):220-8. PubMed ID: 26826926
[TBL] [Abstract][Full Text] [Related]
5. Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus.
Merkle FT; Neuhausser WM; Santos D; Valen E; Gagnon JA; Maas K; Sandoe J; Schier AF; Eggan K
Cell Rep; 2015 May; 11(6):875-883. PubMed ID: 25937281
[TBL] [Abstract][Full Text] [Related]
6. Production of genome-edited pluripotent stem cells and mice by CRISPR/Cas.
Horii T; Hatada I
Endocr J; 2016; 63(3):213-9. PubMed ID: 26743444
[TBL] [Abstract][Full Text] [Related]
7. Generation of an Induced Pluripotent Stem Cell Line with the Constitutive EGFP Reporter.
Butterfield KT; McGrath PS; Han CM; Kogut I; Bilousova G
Methods Mol Biol; 2020; 2155():11-21. PubMed ID: 32474864
[TBL] [Abstract][Full Text] [Related]
8. Generation of eGFP and Cre knockin rats by CRISPR/Cas9.
Ma Y; Ma J; Zhang X; Chen W; Yu L; Lu Y; Bai L; Shen B; Huang X; Zhang L
FEBS J; 2014 Sep; 281(17):3779-90. PubMed ID: 25039742
[TBL] [Abstract][Full Text] [Related]
9. One-Step Generation of Seamless Luciferase Gene Knockin Using CRISPR/Cas9 Genome Editing in Human Pluripotent Stem Cells.
Li M; Hunt JFVS; Bhattacharyya A; Zhao X
Methods Mol Biol; 2019; 1942():61-69. PubMed ID: 30900175
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9-Mediated Fluorescent Tagging of Endogenous Proteins in Human Pluripotent Stem Cells.
Sharma A; Toepfer CN; Ward T; Wasson L; Agarwal R; Conner DA; Hu JH; Seidman CE
Curr Protoc Hum Genet; 2018 Jan; 96():21.11.1-21.11.20. PubMed ID: 29364519
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
Zhang Y; Sastre D; Wang F
Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
[TBL] [Abstract][Full Text] [Related]
12. Generation of Efficient Knock-in Mouse and Human Pluripotent Stem Cells Using CRISPR-Cas9.
Anzai T; Hara H; Chanthra N; Sadahiro T; Ieda M; Hanazono Y; Uosaki H
Methods Mol Biol; 2021; 2320():247-259. PubMed ID: 34302663
[TBL] [Abstract][Full Text] [Related]
13. Generation and Characterization of a MYF5 Reporter Human iPS Cell Line Using CRISPR/Cas9 Mediated Homologous Recombination.
Wu J; Hunt SD; Xue H; Liu Y; Darabi R
Sci Rep; 2016 Jan; 6():18759. PubMed ID: 26729410
[TBL] [Abstract][Full Text] [Related]
14. Improved hematopoietic differentiation efficiency of gene-corrected beta-thalassemia induced pluripotent stem cells by CRISPR/Cas9 system.
Song B; Fan Y; He W; Zhu D; Niu X; Wang D; Ou Z; Luo M; Sun X
Stem Cells Dev; 2015 May; 24(9):1053-65. PubMed ID: 25517294
[TBL] [Abstract][Full Text] [Related]
15. Both TALENs and CRISPR/Cas9 directly target the HBB IVS2-654 (C > T) mutation in β-thalassemia-derived iPSCs.
Xu P; Tong Y; Liu XZ; Wang TT; Cheng L; Wang BY; Lv X; Huang Y; Liu DP
Sci Rep; 2015 Jul; 5():12065. PubMed ID: 26156589
[TBL] [Abstract][Full Text] [Related]
16. Practical method for targeted disruption of cilia-related genes by using CRISPR/Cas9-mediated, homology-independent knock-in system.
Katoh Y; Michisaka S; Nozaki S; Funabashi T; Hirano T; Takei R; Nakayama K
Mol Biol Cell; 2017 Apr; 28(7):898-906. PubMed ID: 28179459
[TBL] [Abstract][Full Text] [Related]
17. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
[TBL] [Abstract][Full Text] [Related]
18. A CRISPR/Cas-Mediated Selection-free Knockin Strategy in Human Embryonic Stem Cells.
Zhu Z; Verma N; González F; Shi ZD; Huangfu D
Stem Cell Reports; 2015 Jun; 4(6):1103-11. PubMed ID: 26028531
[TBL] [Abstract][Full Text] [Related]
19. Generation of a PXR reporter human induced pluripotent stem cell line (PXR-mCherry hiPSC) using the CRISPR/Cas9 system.
Kim H; Kim JW; Kim SJ; Choi YJ; Kim DS; Park HJ
Stem Cell Res; 2018 Jan; 26():72-75. PubMed ID: 29247817
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
Kim EJ; Kang KH; Ju JH
Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
